Management of Librium (Chlordiazepoxide) Overdose
The management of Librium overdose primarily involves supportive care with airway management, ventilatory support, and careful consideration of flumazenil use only in select cases without contraindications. 1
Initial Assessment and Management
- Establish and maintain an open airway as the first priority, providing bag-mask ventilation for respiratory depression, followed by endotracheal intubation when appropriate 1
- Monitor vital signs including respiration, pulse, and blood pressure 2
- Perform immediate gastric lavage for recent ingestions 2
- Administer intravenous fluids to maintain circulation 2
- Contact regional poison center (1-800-222-1222 in the US) for expert guidance in management 1
Supportive Care
- Provide respiratory support as needed - this is the cornerstone of management for benzodiazepine overdose 1
- Treat hypotension with norepinephrine or metaraminol if needed 2
- Monitor for hypoxemia and hypercarbia which are the primary causes of tissue injury and death in benzodiazepine overdose 1
- Dialysis has limited value in benzodiazepine overdose 2
Antidotal Therapy: Flumazenil Considerations
- Flumazenil may be considered in select patients with respiratory depression/arrest caused by pure benzodiazepine poisoning who do not have contraindications 1
- Initial adult dose: 0.2 mg IV, titrated up to 1 mg 1
- Pediatric dose: 0.01 mg/kg 1
Important Contraindications and Cautions for Flumazenil:
Do not use flumazenil in patients with:
Flumazenil may precipitate:
Special Considerations
- If combined opioid and benzodiazepine poisoning is suspected, administer naloxone first before considering other antidotes for respiratory depression 1
- Monitor for resedation, as the duration of action of flumazenil may be shorter than that of chlordiazepoxide 1
- Avoid barbiturates if excitation occurs following chlordiazepoxide overdose 2
- Consider the possibility of multiple drug ingestion, which is common in overdose scenarios 1
Monitoring and Disposition
- Observe patients for an appropriate period after treatment to monitor for resedation, respiratory depression, and other residual benzodiazepine effects 3
- Continue monitoring vital signs until the patient's level of consciousness and vital signs have normalized 1
- For patients who received flumazenil, extended observation is necessary to watch for return of sedation as the antagonist effect wears off 3
Common Pitfalls to Avoid
- Failing to recognize mixed overdoses, especially with opioids or alcohol 1
- Administering flumazenil to patients with benzodiazepine dependence or co-ingestion of tricyclic antidepressants 1
- Assuming flumazenil will fully reverse respiratory depression, particularly in mixed overdoses 1
- Neglecting to provide adequate respiratory support while focusing on pharmacological interventions 1